pmc logo imageJournal ListSearchpmc logo image
Logo of jcinvestCurrent issueArchiveSubscribe to the JCIAbout the JCIThe Journal of Clinical Investigation
J Clin Invest. 1983 August; 72(2): 535–544.
doi: 10.1172/JCI111001.
PMCID: PMC1129211
Early membrane damage during coronary reperfusion in dogs. Detection by radiolabeled anticardiac myosin (Fab')2.
L H Frame, J A Lopez, B A Khaw, J T Fallon, E Haber, and W J Powell, Jr
Abstract
There is currently great interest in acute coronary reperfusion as a therapeutic modality for severe myocardial ischemia. While some studies have demonstrated a reduction in the overall extent of necrosis by early reperfusion, other studies have identified potentially deleterious effects produced by reflow. Because membrane disruption may be an important mechanism of irreversible cell injury, we measured changes in cell membrane integrity early during reperfusion using radiolabeled anticardiac myosin (Fab')2 antibody fragments in dogs. Our method involved brief periods of exposure to the (Fab')2 so that the levels of (Fab')2 binding indicated the degree of membrane disruption at discrete times during the progression of cell injury. In the first protocol (Fab')2 fragments labeled with either 125I and 131I were injected into the left circumflex coronary artery at the onset of reflow and at 45 min of reflow after a 1-h circumflex artery occlusion. Coronary sinus flow was diverted for 5 min following each injection to prevent recirculation. The (Fab')2 binding ratio (ischemic/control) increased during the first 45 min of reflow in each of eight experiments (mean increase 170%, P less than 0.01). No significant increase in (Fab')2 binding was observed in five additional experiments in which nonspecific (Fab')2 was injected. This indicates that the increase in binding seen with antimyosin-specific (Fab')2 was due to changes in specific binding rather than to alterations in (Fab')2 delivery produced by changes in blood flow distribution. The increase in membrane damage during reflow was confirmed by a second protocol in which each animal received only a single left atrial injection of (Fab')2 followed by rapid excision of the heart. The (Fab')2 binding ratio was 1.7 +/- 0.3 (SEM) in the group that received (Fab')2 at the onset of reflow and 3.7 +/- 0.6 (SEM) (P less than 0.05) in the group that received (Fab')2 after 45 min of reflow. In a third set of experiments in which hyperosmotic mannitol was infused during reflow the mean increase in (Fab')2 binding using the first protocol was only 80 +/- 40 vs. 170 +/- 30% without mannitol (P less than 0.05). Thus, membrane damage develops early during coronary reperfusion following 1 h of circumflex coronary artery occlusion, and part of this membrane damage can be prevented by altering the conditions of reflow. A method involving brief exposure of the myocardium to antimyosin (Fab')2 is promising for detecting changes in membrane integrity during evolving ischemic injury.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.4M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • DeWood, MA; Spores, J; Notske, RN; Lang, HT; Shields, JP; Simpson, CS; Rudy, LW; Grunwald, R. Medical and surgical management of myocardial infarction. Am J Cardiol. 1979 Dec;44(7):1356–1364. [PubMed]
  • Cohn, LH; Gorlin, R; Herman, MV; Collins, JJ., Jr Aorto-coronary bypass for acute coronary occlusion. J Thorac Cardiovasc Surg. 1972 Oct;64(4):503–513. [PubMed]
  • Phillips, SJ; Kongtahworn, C; Zeff, RH; Benson, M; Iannone, L; Brown, T; Gordon, DF. Emergency coronary artery revascularization: a possible therapy for acute myocardial infarction. Circulation. 1979 Aug;60(2):241–246. [PubMed]
  • Ganz, W; Ninomiya, K; Hashida, J; Fishbein, MC; Buchbinder, N; Marcus, H; Mondkar, A; Maddahi, J; Shah, PK; Berman, D; Charuzi, Y; Geft, I; Shell, W; Swan, HJ. Intracoronary thrombolysis in acute myocardial infarction: experimental background and clinical experience. Am Heart J. 1981 Dec;102(6 Pt 2):1145–1149. [PubMed]
  • Rentrop, P; Blanke, H; Karsch, KR; Kaiser, H; Köstering, H; Leitz, K. Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris. Circulation. 1981 Feb;63(2):307–317. [PubMed]
  • Reduto, LA; Smalling, RW; Freund, GC; Gould, KL. Intracoronary infusion of streptokinase in patients with acute myocardial infarction: effects of reperfusion on left ventricular performance. Am J Cardiol. 1981 Sep;48(3):403–409. [PubMed]
  • Mathey, DG; Kuck, KH; Tilsner, V; Krebber, HJ; Bleifeld, W. Non surgical coronary artery recanalization in acute transmural myocardial infarction. Circulation. 1981 Mar;63(3):489–497. [PubMed]
  • Whalen, DA, Jr; Hamilton, DG; Ganote, CE; Jennings, RB. Effect of a transient period of ischemia on myocardial cells. I. Effects on cell volume regulation. Am J Pathol. 1974 Mar;74(3):381–397. [PubMed]
  • Kloner, RA; Ganote, CE; Jennings, RB. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest. 1974 Dec;54(6):1496–1508. [PubMed]
  • Kloner, RA; Ganote, CE; Whalen, DA, Jr; Jennings, RB. Effect of a transient period of ischemia on myocardial cells. II. Fine structure during the first few minutes of reflow. Am J Pathol. 1974 Mar;74(3):399–422. [PubMed]
  • Jennings, RB; Ganote, CE; Kloner, RA; Whalen, DA, Jr; Hamilton, DG. Explosive swelling of myocardial cells irreversibly injured by transient ischemia. Recent Adv Stud Cardiac Struct Metab. 1975;6:405–413. [PubMed]
  • Powell, WJ, Jr; DiBona, DR; Flores, J; Leaf, A. The protective effect of hyperosmotic mannitol in myocardial ischemia and necrosis. Circulation. 1976 Oct;54(4):603–615. [PubMed]
  • Willerson, JT; Scales, F; Mukherjee, A; Platt, M; Templeton, GH; Fink, GS; Buja, LM. Abnormal myocardial fluid retention as an early manifestation of ischemic injury. Am J Pathol. 1977 Apr;87(1):159–188. [PubMed]
  • DiBona, DR; Powell, WJ., Jr Quantitative correlation between cell swelling and necrosis in myocardial ischemia in dogs. Circ Res. 1980 Nov;47(5):653–665. [PubMed]
  • Jennings, RB. Cell volume regulation in acute myocardial ischemic injury. Acta Med Scand Suppl. 1976;587:83–93. [PubMed]
  • Khaw, BA; Beller, GA; Haber, E; Smith, TW. Localization of cardiac myosin-specific antibody in myocardial infarction. J Clin Invest. 1976 Aug;58(2):439–446. [PubMed]
  • Khaw, BA; Beller, GA; Haber, E. Experimental myocardial infarct imaging following intravenous administration of iodine-131 labeled antibody (Fab')2 fragments specific for cardiac myosin. Circulation. 1978 Apr;57(4):743–750. [PubMed]
  • Khaw, BA; Gold, HK; Leinbach, RC; Fallon, JT; Strauss, W; Pohost, GM; Haber, E. Early imaging of experimental myocardial infarction by intracoronary administraion of 131I-labelled anticardiac myosin (Fab')2 fragments. Circulation. 1978 Dec;58(6):1137–1142. [PubMed]
  • Khaw, BA; Fallon, JT; Beller, GA; Haber, E. Specificity of localization of myosin-specific antibody fragments in experimental myocardial infarction. Histologic, histochemical, autoradiographic and scintigraphic studies. Circulation. 1979 Dec;60(7):1527–1531. [PubMed]
  • Khaw, BA; Fallon, FT; Strauss, HW; Haber, E. Myocardial infarct imaging of antibodies to canine cardiac myosin with indium-111-diethylenetriamine pentaacetic acid. Science. 1980 Jul 11;209(4453):295–297. [PubMed]
  • Beller, GA; Khaw, BA; Haber, E; Smith, TW. Localization of radiolabeled cardiac myosin-specific antibody in myocardial infarcts. Comparison with technetium-99m stannous pyrophosphate. Circulation. 1977 Jan;55(1):74–78. [PubMed]
  • Khaw, BA; Scott, J; Fallon, JT; Cahill, SL; Haber, E; Homcy, C. Myocardial injury: quantitation by cell sorting initiated with antimyosin fluorescent spheres. Science. 1982 Sep 10;217(4564):1050–1053. [PubMed]
  • Marchalonis, JJ. An enzymic method for the trace iodination of immunoglobulins and other proteins. Biochem J. 1969 Jun;113(2):299–305. [PubMed]
  • Reimer, KA; Lowe, JE; Rasmussen, MM; Jennings, RB. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation. 1977 Nov;56(5):786–794. [PubMed]
  • Lie, JT; Pairolero, PC; Holley, KE; Titus, JL. Macroscopic enzyme-mapping verification of large, homogeneous, experimental myocardial infarcts of predictable size and location in dogs. J Thorac Cardiovasc Surg. 1975 Apr;69(4):599–605. [PubMed]
  • Leaf, A. Cell swelling. A factor in ischemic tissue injury. Circulation. 1973 Sep;48(3):455–458. [PubMed]
  • Bresnahan, GF; Roberts, R; Shell, WE; Ross, J, Jr; Sobel, BE. Deleterious effects due to hemorrhage after myocardial reperfusion. Am J Cardiol. 1974 Jan;33(1):82–86. [PubMed]
  • Maroko, PR; Libby, P; Ginks, WR; Bloor, CM; Shell, WE; Sobel, BE; Ross, J., Jr Coronary artery reperfusion. I. Early effects on local myocardial function and the extent of myocardial necrosis. J Clin Invest. 1972 Oct;51(10):2710–2716. [PubMed]
  • Ginks, WR; Sybers, HD; Maroko, PR; Covell, JW; Sobel, BE; Ross, J., Jr Coronary artery reperfusion. II. Reduction of myocardial infarct size at 1 week after the coronary occlusion. J Clin Invest. 1972 Oct;51(10):2717–2723. [PubMed]
  • Baughman, KL; Maroko, PR; Vatner, SF. Effects of coronary artery reperfusion on myocardial infarct size and survival in conscious dogs. Circulation. 1981 Feb;63(2):317–323. [PubMed]